InvestorsHub Logo
Followers 1
Posts 77
Boards Moderated 0
Alias Born 11/25/2015

Re: Amatuer17 post# 3468

Thursday, 09/20/2018 10:38:54 AM

Thursday, September 20, 2018 10:38:54 AM

Post# of 3839
But still it is 17%more than keytruba alone plus 2 patients stabilized makes over 60. Not bad for hard to treat patients.
Plus this is only 1b trial about safety. There is some room to play with dosage and length of the therapy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News